Literature DB >> 12483371

Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease) associated with antiphospholipid syndrome: case report and literature review.

G Papaioannou1, M Speletas, V Kaloutsi, A Pavlitou-Tsiontsi.   

Abstract

Histiocytic necrotizing lymphadenitis (HNL), or Kikuchi-Fujimoto disease, is a benign, self-limited disease that predominantly occurs in women. The etiology remains undetermined, although a viral or autoimmune hypothesis has been suggested. The disease usually emerges with cervical lymphadenopathy with or without fever. The diagnosis can be confirmed only by histological findings of lymph node biopsy, characterized by necrosis and histiocytic infiltration without neutrophils. We report a case of a 28-year-old woman with a medical history of two episodes of unexplained pulmonary embolisms (3 and 2 years previously) who was admitted to our hospital because of unilateral cervical lymphadenopathy and mild fever that presented 1 week before admission. A diagnosis of HNL was performed by lymph node biopsy. In parallel, whereas the laboratory tests for inherited thrombophilia were negative, a progressive elevated titer of anti-beta(2) glycoprotein I (GPI) antibodies was established. Because of persistent fever, the patient received a short course of corticosteroid therapy and she recovered completely from the HNL after 2 months. It is noteworthy that to date the patient has displayed an elevated titer of anti-beta(2) GPI antibodies (18 months after the recovery from the HNL). Thus, considering the previous history of venous thrombosis and the presence of antiphospholipid antibodies, the diagnosis of primary antiphospholipid syndrome associated with HNL was made. To our knowledge, this is the first report in the literature describing antiphospholipid syndrome associated with HNL. Moreover, a brief literature review is provided with emphasis on the etiology, clinical course, and pathogenesis of this rare disease entity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12483371     DOI: 10.1007/s00277-002-0562-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  6 in total

1.  Kikuchi-Fujimoto disease: a case report.

Authors:  Antoni Hrycek; Paweł Cieślik; Witold Szkróbka; Jacek Pajak
Journal:  Rheumatol Int       Date:  2005-06-10       Impact factor: 2.631

2.  Risk Assessment of Recurrence and Autoimmune Disorders in Kikuchi Disease.

Authors:  Hyun Joo Jung; Il Jae Lee; Seung-Hyun Yoon
Journal:  Risk Manag Healthc Policy       Date:  2020-09-22

3.  Kikuchi's disease.

Authors:  Benjamin Rhodes; Ali S M Jawad
Journal:  J R Soc Med       Date:  2004-10       Impact factor: 18.000

Review 4.  Bilateral pleural effusion and interstitial lung disease as unusual manifestations of Kikuchi-Fujimoto disease: case report and literature review.

Authors:  Alberto Garcia-Zamalloa; Jorge Taboada-Gomez; Pilar Bernardo-Galán; Fernandez-Martinez Magdalena; Laura Zaldumbide-Dueñas; Mario Ugarte-Maiztegui
Journal:  BMC Pulm Med       Date:  2010-11-05       Impact factor: 3.317

5.  Histiocytic necrotising lymphadenitis (Kikuchi-Fujimoto disease) in Saudi Arabia: clinicopathology and immunohistochemistry.

Authors:  Jaudah Al-Maghrabi; Hassan Kanaan
Journal:  Ann Saudi Med       Date:  2005 Jul-Aug       Impact factor: 1.526

6.  Kikuchi's lymphadenopathy: a relatively rare but important cause of lymphadenopathy in Greece, potentially associated with the antiphospholipid syndrome.

Authors:  Theodoros P Vassilakopoulos; Gerassimos A Pangalis; Marina P Siakantaris; Georgia Levidou; Xanthi Yiakoumis; Charalambos Floudas; Despina Gribabis; Spyridon Bouros; Ioannis Metaxas; Evangelia M Dimitriadou; Lambrini Pantazi; Catherine Tsoukala; Penelope Korkolopoulou; Anastasios Andreopoulos; George Vaiopoulos
Journal:  Rheumatol Int       Date:  2009-08-20       Impact factor: 3.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.